BRAK is a new type marker for development of tailor made medicine in head and neck squamous cell carcinoma.
BRAK is a new type marker for development of tailor made medicine in head and neck squamous cell carcinoma.
批准号:
21792037
负责人:
OZAWA Shigeyuki
金额:
$2.83万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Young Scientists (B)
财政年份:
2009
资助国家:
日本
项目状态:
已结题
起止时间:
2009 至 2010
中文摘要
点击翻译按钮获取中文摘要
英文摘要
BRAK is not expressed or negligible level in head and neck squamous cell carcinoma. We cleared that methylation of BRAK promoter regulates the expression of BRAK as a negative regulator.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Expression of BRAK/CXCL14 is associated with antitumor efficacy of gefitinib in head and neck squamous cell carcinoma.
BRAK/CXCL14 的表达与吉非替尼在头颈鳞状细胞癌中的抗肿瘤功效相关。
DOI:
--
发表时间:
2009
期刊:
影响因子:
--
作者:
[Shigeyuki Ozawa, Yasumasa Kato, Shin Ito, Reika Komori, Kenji Suzuki, Keiichi Tsukinoki, Yojiro Maehata, Takahide Taguchi, Yukari Imagawa-Ishiguro, Mamoru Tsukuda, Eiro Kubota, Ryu-Ichiro Hata]
通讯作者:
Ryu-Ichiro Hata
Chemokine BRAK/CXCL14 is a multifunctional tumor suppressor.
趋化因子 BRAK/CXCL14 是一种多功能肿瘤抑制因子。
DOI:
--
发表时间:
2010
期刊:
影响因子:
--
作者:
[Hata R, Izukuri K, Suzuki K, Yajima N, Ozawa S, Ito S, Kubota E]
通讯作者:
Kubota E
DOI:
10.2220/biomedres.30.315
发表时间:
2009-10-01
期刊:
BIOMEDICAL RESEARCH-TOKYO
影响因子:
1.2
作者:
[Ozawa, Shigeyuki, Kato, Yasumasa, Hata, Ryu-Ichiro]
通讯作者:
Hata, Ryu-Ichiro
DOI:
10.1111/j.1349-7006.2009.01281.x
发表时间:
2009-11-01
期刊:
CANCER SCIENCE
影响因子:
5.7
作者:
[Ozawa, Shigeyuki, Kato, Yasumasa, Hata, Ryu-Ichiro]
通讯作者:
Hata, Ryu-Ichiro
Chemokine BRAK stimulates apoptosis elicited by gefitinib in oral squamous cell carcinoma
趋化因子 BRAK 刺激吉非替尼在口腔鳞状细胞癌中引起的细胞凋亡
DOI:
--
发表时间:
2009
期刊:
影响因子:
--
作者:
[Ito S, Ozawa S, Shiiki N, Tsukinoki K, Kubota E, Kato Y, Taguchi T, Imagawa-Ishiguro Y, Tsukuda M, Hata R]
通讯作者:
Hata R
Combination chemotherapy for head and neck squamous cell carcinoma
-
批准号:19791553
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$2.25万
-
财政年份:2007
-
负责人:OZAWA Shigeyuki
-
依托单位:
海外基金